ARCH Venture Partners XII, LLC has bought stock on 9 days since Sep 2023

Arch Venture Partners XII, LLC is a Delaware-incorporated limited liability company (CIK: 0001979548) serving as the general partner of ARCH Venture Partners XII, L.P., the investment vehicle associated with ARCH Venture Fund's XII, which closed at $2.975 billion in June 2022 to fund early-stage biotechnology companies focused on breakthrough technologies in areas like neurology, oncology, and mental health.( As a corporate insider and 10% owner of Neumora Therapeutics, Inc. (NMRA), it has engaged in recent trading activities related to the company's shares.(

Arch Venture Partners XII, LLC operates within the broader ARCH Venture Partners ecosystem, a Chicago-based venture capital firm founded in 1986, renowned for co-founding and investing in over 130 active early-stage companies in life sciences, biotechnology, and deep-tech from top research institutions.( The firm, with assets under management exceeding $10 billion, is led by managing directors including Keith Crandell, who signs on behalf of the entity, alongside co-founders Robert Nelsen and Kristina Burow.( ARCH emphasizes partnering with scientists to commercialize disruptive science, providing not just capital but operational support in company building and leadership assembly.(

Written by Perplexity from public sources.